BLUW

NASDAQ

Blue Water Acquisition Corp. III

IPO2025

News25/Ratings0

Blue Water Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Greenwich, Connecticut.

Latest news

25 items

315dINSIDER
Large owner Blue Water Acquisition Iii Llc bought 430,000 units of Class A ordinary shares (SEC Form 4)
4 - Blue Water Acquisition Corp. III (0002050501) (Issuer)
315dINSIDER
SEC Form 3 filed by new insider Blue Water Acquisition Iii Llc
3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)
315dINSIDER
Amendment: SEC Form 3 filed by new insider Hernandez Joseph
3/A - Blue Water Acquisition Corp. III (0002050501) (Issuer)
315dINSIDER
Chief Executive Officer Hernandez Joseph bought 430,000 units of Class A ordinary shares (SEC Form 4)
4 - Blue Water Acquisition Corp. III (0002050501) (Issuer)
315dSEC
Blue Water Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
8-K - Blue Water Acquisition Corp. III (0002050501) (Filer)
317dSEC
SEC Form 424B4 filed by Blue Water Acquisition Corp.
424B4 - Blue Water Acquisition Corp. III (0002050501) (Filer)
317dSEC
SEC Form CERT filed by Blue Water Acquisition Corp.
CERT - Blue Water Acquisition Corp. III (0002050501) (Filer)
318dSEC
SEC Form EFFECT filed by Blue Water Acquisition Corp.
EFFECT - Blue Water Acquisition Corp. III (0002050501) (Filer)
318dSEC
SEC Form S-1MEF filed by Blue Water Acquisition Corp.
S-1MEF - Blue Water Acquisition Corp. III (0002050501) (Filer)
318dINSIDER
New insider Hernandez Joseph claimed ownership of 6,325,000 units of Class B ordinary shares (SEC Form 3)
3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)
318dINSIDER
SEC Form 3 filed by new insider Hermouet Laurent Didier
3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)
318dINSIDER
SEC Form 3 filed by new insider Dugal Ishdeep
3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)
318dINSIDER
SEC Form 3 filed by new insider Coulson Timothy Neal
3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)
318dINSIDER
SEC Form 3 filed by new insider Hawkins Trevor Leonard
3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)
318dINSIDER
SEC Form 3 filed by new insider Ross Martha F.
3 - Blue Water Acquisition Corp. III (0002050501) (Issuer)
318dSEC
SEC Form 8-A12B filed by Blue Water Acquisition Corp.
8-A12B - Blue Water Acquisition Corp. III (0002050501) (Filer)
322dSEC
Amendment: SEC Form S-1/A filed by Blue Water Acquisition Corp.
S-1/A - Blue Water Acquisition Corp. III (0002050501) (Filer)
335dSEC
Amendment: SEC Form S-1/A filed by Blue Water Acquisition Corp.
S-1/A - Blue Water Acquisition Corp. III (0002050501) (Filer)
388dSEC
Amendment: SEC Form S-1/A filed by Blue Water Acquisition Corp.
S-1/A - Blue Water Acquisition Corp. III (0002050501) (Filer)
1687dPR
Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies
Business combination with Blue Water Acquisition Corp., a special purpose acquisition company, completed on September 9, 2021 Combined company to be renamed Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc.'s common stock and warrants will commence trading on the Nasdaq Global Market on September 10, 2021, under the ticker symbols "CRXT" and "CRXTW," respectively Gross proceeds totaled approximately $25.3 million NORTHBROOK, Ill. and GREENWICH, Conn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a specialty pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women (
1700dPR
Blue Water Acquisition Corp. Announces Stockholder Approval of Business Combination with Clarus Therapeutics, Inc.
GREENWICH, Conn., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ:BLUW), a special purpose acquisition company ("Blue Water"), today announced that its stockholders have voted to approve the proposed business combination (the "Business Combination") with Clarus Therapeutics, Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women ("Clarus") at its special meeting of stockholders (the "Special Meeting") held today, August 27, 2021. Holders of approximately 73.95% of Blue Water's issued and outstanding shares cast votes at the Special Meeting. Approximately 69.57% o
1716dPR
Blue Water Acquisition Corp. Announces Change of Special Meeting of Shareholders Date to August 27, 2021
NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUW) ("Blue Water" or the "Company"), a special purpose acquisition company (SPAC) that previously announced a planned business combination with Clarus Therapeutics, Inc. ("Clarus"), announced today that the special meeting of its stockholders (the "Special Meeting") originally scheduled for Thursday, August 12, 2021, is being postponed to Friday, August 27, 2021. As a result of this change, the Special Meeting will now be held at 10:00 a.m., Eastern Time, on August 27, 2021, exclusively via a live audio webcast at https://www.cstproxy.com/bluewateracquisition/2021. Also as a result of this c
1728dPR
Blue Water Acquisition Corp. Announces Date for Special Meeting of Stockholders to Vote on Transaction With Clarus Therapeutics, Inc.
GREENWICH, Conn., July 30, 2021 /PRNewswire/ -- Blue Water Acquisition Corp. (NASDAQ:BLUW) ("Blue Water"), a special purpose acquisition company ("SPAC") led by Joseph Hernandez, today announced that it has scheduled a special meeting of its stockholders (the "Special Meeting") to, among other things, consider and vote on a proposal to approve the transactions contemplated by the previously announced merger agreement pursuant to which Clarus Therapeutics, Inc. ("Clarus") will merge with a wholly-owned subsidiary of Blue Water (the "Business Combination") and seek to become a publicly listed company. Subject to stockholder approval and satisfaction of customary closing conditions, Clarus and
1763dSEC
SEC Form S-4/A filed by Blue Water Acquisition Corp. (Amendment)
S-4/A - Blue Water Acquisition Corp. (0001817944) (Filer)
1794dSEC
SEC Form 425 filed by Blue Water Acquisition Corp.
425 - Blue Water Acquisition Corp. (0001817944) (Subject)